Garadacimab: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Garadacimab. Educational only — not medical advice.

Labeled uses

ANDEMBRY is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

Source: FDA labeling via NIH DailyMed (set 07b0b671…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.